Clinical Trials Directory

Trials / Unknown

UnknownNCT00768625

Cardiovascular Risk Stratification in Patients With Obstructive Sleep Apnea

Status
Unknown
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Associacao Fundo de Incentivo a Psicofarmcologia · Academic / Other
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is: 1. To determine the frequency of cardiovascular diseases in patients with OSA, obese, overweight, and lean (BMI\<25) 2. To analyze the CPAP treatment over the clinical evolution of OSA patients 3. To determine if OSA is a independent predictor of cardiovascular risk

Detailed description

Obstructive Sleep Apnea (OSA) is a condition with important cardiovascular repercussions. However, the association between OSA, cardiovascular diseases, and obesity has not been totally clarified. We hypothesized that the cardiovascular consequences of OSA are due to obesity.

Conditions

Timeline

Start date
2005-04-01
Primary completion
2011-03-01
Completion
2012-12-01
First posted
2008-10-08
Last updated
2008-10-08

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00768625. Inclusion in this directory is not an endorsement.

Cardiovascular Risk Stratification in Patients With Obstructive Sleep Apnea (NCT00768625) · Clinical Trials Directory